OTLK icon

Outlook Therapeutics

16 hedge funds and large institutions have $18.2M invested in Outlook Therapeutics in 2016 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 3 closing their positions.

Holders
16
Holders Change
-2
Holders Change %
-11.11%
% of All Funds
0.4%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
1
Increased
4
Reduced
8
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
SM
1
Sabby Management
Florida
$6.74M 2,238,470 -30,115 -1%
PA
2
Perceptive Advisors
New York
$3.76M 1,248,990
CAM
3
Cormorant Asset Management
Massachusetts
$2.51M 833,333 -193,883 -19%
ACA
4
Avoro Capital Advisors
New York
$2.06M 683,531 +232,659 +52%
Vanguard Group
5
Vanguard Group
Pennsylvania
$841K 279,273 +186,158 +200%
Marshall Wace
6
Marshall Wace
United Kingdom
$788K 261,800 +11,600 +5%
SFM
7
Sphera Funds Management
Israel
$525K 174,477 -25,523 -13%
Goldman Sachs
8
Goldman Sachs
New York
$390K 129,705 -994 -0.8%
JG
9
Jefferies Group
New York
$296K 98,300
Millennium Management
10
Millennium Management
New York
$177K 58,912 -25,588 -30%
ACP
11
Acuta Capital Partners
California
$88K 29,082 -216,309 -88%
Morgan Stanley
12
Morgan Stanley
New York
$45K 14,900 -3,000 -17%
JAM
13
JW Asset Management
Florida
$16K 5,162 +5,162 New
UBS Group
14
UBS Group
Switzerland
$9K 2,943 +907 +45%
PC
15
PointState Capital
New York
-200,000 Closed
Bank of America
16
Bank of America
North Carolina
$0 1 -19,520 -100%
VKH
17
Virtu KCG Holdings
New York
-10,017 Closed
TRCT
18
Tower Research Capital (TRC)
New York
-700 Closed
Wells Fargo
19
Wells Fargo
California
$0 100